Статті в журналах з теми "Nanoparticle-based vaccines"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Nanoparticle-based vaccines".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Heuts, Jeroen, Wim Jiskoot, Ferry Ossendorp, and Koen van der Maaden. "Cationic Nanoparticle-Based Cancer Vaccines." Pharmaceutics 13, no. 5 (April 21, 2021): 596. http://dx.doi.org/10.3390/pharmaceutics13050596.
Повний текст джерелаStephens, Laura M., and Steven M. Varga. "Nanoparticle vaccines against respiratory syncytial virus." Future Virology 15, no. 11 (November 2020): 763–78. http://dx.doi.org/10.2217/fvl-2020-0174.
Повний текст джерелаMarasini, Nirmal, Mariusz Skwarczynski, and Istvan Toth. "Intranasal delivery of nanoparticle-based vaccines." Therapeutic Delivery 8, no. 3 (March 2017): 151–67. http://dx.doi.org/10.4155/tde-2016-0068.
Повний текст джерелаMarasini, Nirmal, Mariusz Skwarczynski, and Istvan Toth. "Oral delivery of nanoparticle-based vaccines." Expert Review of Vaccines 13, no. 11 (August 26, 2014): 1361–76. http://dx.doi.org/10.1586/14760584.2014.936852.
Повний текст джерелаBezbaruah, Rajashri, Vivek P. Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee, and Lalitkumar Vora. "Nanoparticle-Based Delivery Systems for Vaccines." Vaccines 10, no. 11 (November 17, 2022): 1946. http://dx.doi.org/10.3390/vaccines10111946.
Повний текст джерелаDu, Lanying, Yang Yang, Xiujuan Zhang, and Fang Li. "Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies." Nanoscale 14, no. 4 (2022): 1054–74. http://dx.doi.org/10.1039/d1nr03831a.
Повний текст джерелаBernasconi, Valentina, Karin Norling, Marta Bally, Fredrik Höök, and Nils Y. Lycke. "Mucosal Vaccine Development Based on Liposome Technology." Journal of Immunology Research 2016 (2016): 1–16. http://dx.doi.org/10.1155/2016/5482087.
Повний текст джерелаZhang, Naru, Qianting Ji, Zezhong Liu, Kaiming Tang, Yubin Xie, Kangchen Li, Jie Zhou, et al. "Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant." Viruses 14, no. 3 (February 28, 2022): 501. http://dx.doi.org/10.3390/v14030501.
Повний текст джерелаSung, Hyo-Dong, Nayeon Kim, Yeram Lee, and Eun Jung Lee. "Protein-Based Nanoparticle Vaccines for SARS-CoV-2." International Journal of Molecular Sciences 22, no. 24 (December 14, 2021): 13445. http://dx.doi.org/10.3390/ijms222413445.
Повний текст джерелаHu, Yun, Daniel Smith, Zongmin Zhao, Theresa Harmon, Paul R. Pentel, Marion Ehrich, and Chenming Zhang. "Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine." Nanomedicine: Nanotechnology, Biology and Medicine 20 (August 2019): 102023. http://dx.doi.org/10.1016/j.nano.2019.102023.
Повний текст джерелаPoudel, Uddab, Saurav Pantha, and Krishna Kaphle. "The status of development of nanoparticle-based swine influenza vaccines: A review." Journal of Biomedical Sciences 6, no. 1 (October 27, 2019): 6–11. http://dx.doi.org/10.3126/jbs.v6i1.26161.
Повний текст джерелаWieczorek, Klaudia, Barbara Szutkowska, and Elzbieta Kierzek. "Anti-Influenza Strategies Based on Nanoparticle Applications." Pathogens 9, no. 12 (December 3, 2020): 1020. http://dx.doi.org/10.3390/pathogens9121020.
Повний текст джерелаLebel, Marie-Ève, Karine Chartrand, Denis Leclerc, and Alain Lamarre. "Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants." Vaccines 3, no. 3 (August 5, 2015): 620–37. http://dx.doi.org/10.3390/vaccines3030620.
Повний текст джерелаPulliam, Brian, Jean C. Sung, and David A. Edwards. "Design of nanoparticle-based dry powder pulmonary vaccines." Expert Opinion on Drug Delivery 4, no. 6 (October 31, 2007): 651–63. http://dx.doi.org/10.1517/17425247.4.6.651.
Повний текст джерелаGuerrini, Giuditta, Sabrina Gioria, Aisha V. Sauer, Simone Lucchesi, Francesca Montagnani, Gabiria Pastore, Annalisa Ciabattini, Donata Medaglini, and Luigi Calzolai. "Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration." International Journal of Molecular Sciences 23, no. 16 (August 9, 2022): 8838. http://dx.doi.org/10.3390/ijms23168838.
Повний текст джерелаChandrasekar, Shaswath S., Yashdeep Phanse, Mariah Riel, Rachel E. Hildebrand, Mostafa Hanafy, Jorge E. Osorio, Sherein S. Abdelgayed, and Adel M. Talaat. "Systemic Neutralizing Antibodies and Local Immune Responses Are Critical for the Control of SARS-CoV-2." Viruses 14, no. 6 (June 10, 2022): 1262. http://dx.doi.org/10.3390/v14061262.
Повний текст джерелаCappelli, Luigia, Paolo Cinelli, Fabiola Giusti, Ilaria Ferlenghi, Sabrina Utrio-Lanfaloni, Newton Wahome, Matthew James Bottomley, Domenico Maione та Roberta Cozzi. "Self-assembling protein nanoparticles and virus like particles correctly display β-barrel from meningococcal factor H-binding protein through genetic fusion". PLOS ONE 17, № 9 (16 вересня 2022): e0273322. http://dx.doi.org/10.1371/journal.pone.0273322.
Повний текст джерелаSemple, Sean C., Robert Leone, Christopher J. Barbosa, Ying K. Tam, and Paulo J. C. Lin. "Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics." Pharmaceutics 14, no. 2 (February 11, 2022): 398. http://dx.doi.org/10.3390/pharmaceutics14020398.
Повний текст джерелаChen, Long, Hao Qin, Ruifang Zhao, Xiao Zhao, Liangru Lin, Yang Chen, Yixuan Lin, et al. "Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines." Science Translational Medicine 13, no. 601 (July 7, 2021): eabc2816. http://dx.doi.org/10.1126/scitranslmed.abc2816.
Повний текст джерелаKhan, Masood Alam, and Arif Khan. "Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines." Vaccines 9, no. 9 (August 26, 2021): 949. http://dx.doi.org/10.3390/vaccines9090949.
Повний текст джерелаChen, Pu-Guang, Zhi-Hua Huang, Zhan-Yi Sun, Yue Gao, Yan-Fang Liu, Lei Shi, Yong-Xiang Chen, Yu-Fen Zhao, and Yan-Mei Li. "Chitosan nanoparticles based nanovaccines for cancer immunotherapy." Pure and Applied Chemistry 89, no. 7 (July 26, 2017): 931–39. http://dx.doi.org/10.1515/pac-2016-0913.
Повний текст джерелаLiu, Ting, Yang Tian, Aiping Zheng, and Chunying Cui. "Design Strategies for and Stability of mRNA–Lipid Nanoparticle COVID-19 Vaccines." Polymers 14, no. 19 (October 6, 2022): 4195. http://dx.doi.org/10.3390/polym14194195.
Повний текст джерелаZhao, Zongmin, Yun Hu, Theresa Harmon, Paul Pentel, Marion Ehrich, and Chenming Zhang. "Effect of Adjuvant Release Rate on the Immunogenicity of Nanoparticle-Based Vaccines: A Case Study with a Nanoparticle-Based Nicotine Vaccine." Molecular Pharmaceutics 16, no. 6 (May 10, 2019): 2766–75. http://dx.doi.org/10.1021/acs.molpharmaceut.9b00279.
Повний текст джерелаGourapura, Renukaradhya J., Ninoshkaly Feliciano-Ruiza, Sankar Renu, Fangjia Lu, Yi Han, Jennifer Schrock, Santosh Dhakal, Veerupaxagouda Patil, and Harm HogenEsch. "Corn based nanoparticle delivered inactivated influenza virus vaccine intranasally augments mucosal immune response in pigs." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 166.4. http://dx.doi.org/10.4049/jimmunol.204.supp.166.4.
Повний текст джерелаGeng, Qibin, Wanbo Tai, Victoria K. Baxter, Juan Shi, Yushun Wan, Xiujuan Zhang, Stephanie A. Montgomery, et al. "Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection." PLOS Pathogens 17, no. 9 (September 7, 2021): e1009897. http://dx.doi.org/10.1371/journal.ppat.1009897.
Повний текст джерелаKhandker, Shahad Saif, Brian Godman, Md Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md Ahsanul Haq, et al. "A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues." Vaccines 9, no. 12 (November 24, 2021): 1387. http://dx.doi.org/10.3390/vaccines9121387.
Повний текст джерелаXia, Ming, Pengwei Huang, Xi Jiang, and Ming Tan. "A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses." Viruses 13, no. 1 (January 6, 2021): 72. http://dx.doi.org/10.3390/v13010072.
Повний текст джерелаHu, Yun, Zongmin Zhao, Theresa Harmon, Paul R. Pentel, Marion Ehrich, and Chenming Zhang. "Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines." Biomaterials 182 (November 2018): 72–81. http://dx.doi.org/10.1016/j.biomaterials.2018.08.015.
Повний текст джерелаMurji, Amyn A., Juliana S. Qin, Tandile Hermanus, Lynn Morris, and Ivelin S. Georgiev. "Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms." Viruses 13, no. 7 (July 2, 2021): 1296. http://dx.doi.org/10.3390/v13071296.
Повний текст джерелаMir, Iqra, Sania Aamir, Syed Rizwan Hussain Shah, Muhammad Shahid, Iram Amin, Samia Afzal, Amjad Nawaz, Muhammad Umer Khan, and Muhammad Idrees. "Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic." Osong Public Health and Research Perspectives 13, no. 2 (April 30, 2022): 84–100. http://dx.doi.org/10.24171/j.phrp.2022.0024.
Повний текст джерелаZeigler, David F., Emily Gage, and Christopher H. Clegg. "Epitope-targeting platform for broadly protective influenza vaccines." PLOS ONE 16, no. 5 (May 27, 2021): e0252170. http://dx.doi.org/10.1371/journal.pone.0252170.
Повний текст джерелаDamm, Dominik, Leonardo Rojas-Sánchez, Hannah Theobald, Viktoriya Sokolova, Richard T. Wyatt, Klaus Überla, Matthias Epple, and Vladimir Temchura. "Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help." Nanomaterials 9, no. 10 (September 27, 2019): 1389. http://dx.doi.org/10.3390/nano9101389.
Повний текст джерелаJoyce, M. G., Wei-Hung Chen, Rajeshwer Sankhala, Agnes Hajduczki, Paul Thomas, Elizabeth Martinez, Caroline Peterson, Mangala Rao, and Kayvon Modjarrad. "564. SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity." Open Forum Infectious Diseases 8, Supplement_1 (November 1, 2021): S384. http://dx.doi.org/10.1093/ofid/ofab466.762.
Повний текст джерелаNie, Ying, Lu Shi, Yanan Zhang, Yunfei Guo, and Hongchen Gu. "Mannose and Hyaluronic Acid Dual-Modified Iron Oxide Enhances Neoantigen-Based Peptide Vaccine Therapy by Polarizing Tumor-Associated Macrophages." Cancers 14, no. 20 (October 18, 2022): 5107. http://dx.doi.org/10.3390/cancers14205107.
Повний текст джерелаAves, Kara-Lee, Christoph M. Janitzek, Cyrielle E. Fougeroux, Thor G. Theander, and Adam F. Sander. "Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature." Pharmaceutics 14, no. 6 (June 18, 2022): 1301. http://dx.doi.org/10.3390/pharmaceutics14061301.
Повний текст джерелаKoyande, Navami Prabhakar, Rupali Srivastava, Ananya Padmakumar, and Aravind Kumar Rengan. "Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review." Vaccines 10, no. 10 (October 16, 2022): 1727. http://dx.doi.org/10.3390/vaccines10101727.
Повний текст джерелаBerti, Cristiana, Michele Graciotti, Alice Boarino, Chakradhar Yakkala, Lana E. Kandalaft, and Harm‐Anton Klok. "Polymer Nanoparticle‐Mediated Delivery of Oxidized Tumor Lysate‐Based Cancer Vaccines." Macromolecular Bioscience 22, no. 2 (December 6, 2021): 2100356. http://dx.doi.org/10.1002/mabi.202100356.
Повний текст джерелаDoekhie, Aswin, Rajeev Dattani, Yun-Chu Chen, Francoise Koumanov, Karen J. Edler, Jean M. H. van den Elsen, and Asel Sartbaeva. "Physiochemical Changes to TTCF Ensilication Investigated Using Time-Resolved SAXS." AppliedChem 1, no. 1 (August 5, 2021): 4–13. http://dx.doi.org/10.3390/appliedchem1010002.
Повний текст джерелаTruong, Hannah Hanh-Hong, Waleed M. Hussein, Tzu-Yu Liu, Zhongfan Jia, James W. Wells, Michael J. Monteiro, Mariusz Skwarczynski, and Mariusz Skwarczynski. "Self-Adjuvanting Peptide Vaccines Against Cervical Cancer." Vaccination Research – Open Journal 4, no. 1 (December 31, 2019): 21–29. http://dx.doi.org/10.17140/vroj-4-114.
Повний текст джерелаSengupta, Anirban, Mohammad Azharuddin, Noha Al-Otaibi, and Jorma Hinkula. "Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases." Vaccines 10, no. 4 (March 24, 2022): 505. http://dx.doi.org/10.3390/vaccines10040505.
Повний текст джерелаVragniau, Charles, Joshua C. Bufton, Frédéric Garzoni, Emilie Stermann, Fruzsina Rabi, Céline Terrat, Mélanie Guidetti, et al. "Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display." Science Advances 5, no. 9 (September 2019): eaaw2853. http://dx.doi.org/10.1126/sciadv.aaw2853.
Повний текст джерелаZhao, Kai, Yinzhuo Xie, Xuezheng Lin, and Wei Xu. "The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines." International Journal of Nanomedicine Volume 17 (September 2022): 4579–98. http://dx.doi.org/10.2147/ijn.s359118.
Повний текст джерелаChan, Yinghan, Sin Wi Ng, Sachin Kumar Singh, Monica Gulati, Gaurav Gupta, Sushil Kumar Chaudhary, Goh Bey Hing, et al. "Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective." Life Sciences 280 (September 2021): 119744. http://dx.doi.org/10.1016/j.lfs.2021.119744.
Повний текст джерелаBrito Baleeiro, R., M. Schweinlin, R. Rietscher, A. Diedrich, J. A. Czaplewska, M. Metzger, C. Michael Lehr, et al. "Nanoparticle-Based Mucosal Vaccines Targeting Tumor-Associated Antigens to Human Dendritic Cells." Journal of Biomedical Nanotechnology 12, no. 7 (July 1, 2016): 1527–43. http://dx.doi.org/10.1166/jbn.2016.2267.
Повний текст джерелаRenukaradhya, Gourapura J., Balaji Narasimhan, and Surya K. Mallapragada. "Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation." Journal of Controlled Release 219 (December 2015): 622–31. http://dx.doi.org/10.1016/j.jconrel.2015.09.047.
Повний текст джерелаLin, Leon Chien-Wei, Saborni Chattopadhyay, Jung-Chen Lin, and Che-Ming Jack Hu. "Advances and Opportunities in Nanoparticle- and Nanomaterial-Based Vaccines against Bacterial Infections." Advanced Healthcare Materials 7, no. 13 (March 6, 2018): 1701395. http://dx.doi.org/10.1002/adhm.201701395.
Повний текст джерелаBjörgvinsdóttir, Unnur Jóna, Laura Stentoft Carstensen, Anna Colliander, Ditte Elisabeth Jæhger, Gael Clergeaud Veiga, Hólmfríður Rósa Halldórsdóttir, Matilde Smærup Jørgensen, et al. "771 Novel lipid nanoparticle vaccine platform for efficient delivery of high- and low-affinity epitopes." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A806. http://dx.doi.org/10.1136/jitc-2021-sitc2021.771.
Повний текст джерелаLundstrom, Kenneth. "Viral Vectors for COVID-19 Vaccine Development." Viruses 13, no. 2 (February 19, 2021): 317. http://dx.doi.org/10.3390/v13020317.
Повний текст джерелаBarnowski, Cornelia, Nicole Kadzioch, Dominik Damm, Huimin Yan, and Vladimir Temchura. "Advantages and Limitations of Integrated Flagellin Adjuvants for HIV-Based Nanoparticle B-Cell Vaccines." Pharmaceutics 11, no. 5 (May 1, 2019): 204. http://dx.doi.org/10.3390/pharmaceutics11050204.
Повний текст джерелаMiao, Jing, Peng Gao, Qian Li, Kaifeng He, Liwen Zhang, Junyan Wang, and Lingfei Huang. "Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review." International Journal of Molecular Sciences 22, no. 20 (October 18, 2021): 11227. http://dx.doi.org/10.3390/ijms222011227.
Повний текст джерела